Skip Navigation
 
 
 
 xxx
 
Print This Page
Share this page: More
 

Technology Center for Networks & Pathways

DNA double helix graphic

We are mourning the loss of our colleague, Professor Robert "Bob" J. Cotter who passed away unexpectedly last November (2012). A memorial symposium will be help at the JHU Medical School Campus on Wednesday, November 20, 2013.  Please see TCNP News for more details.

As of August 1, 2012, we are accepting proposals for "Midi-Driving Biological Projects", i.e. small-scale funding for pilot projects that leverage TCNP technologies.  Proposals may be submitted on a rolling basis.  Please see the RFP.

Click here for TCNP news.

The amino acid lysine is emerging as important in a wide range of biological processes, from control of gene expression to recycling of proteins. Lysine is unique among the amino acids because it can be modified in many ways, ranging from the addition of small functional groups to entire proteins, and these modifications have profound biological effects. For example, protein modification of lysines found on DNA-coiling histones is critical for epigenetic control of gene expression, which itself dictates the expression of the proteome in all cells. Other lysine modifications include acetylation, methylation, ubiquitylation and sumoylation. Among these, ubiquitylation is most well-understood; it controls proteins' life, death and trafficking, among other roles.

In general, these modifications and the pathways regulating their interplay are poorly understood. Studying these networks is no small task -- many lysine-modifying proteins have multiple substrates and are encoded by multi-gene families with redundant activities.

Through our TCNP project, we will dissect these signaling networks and pathways by developing and applying genetic and computational approaches, proteomics technologies, mass spectrometry technologies, single-cell profiling and other novel methods to detect, quantify and monitor lysine modifications.

Among the specific technologies to be developed and used are: innovative proteomics technology, protein microarrays, and a new affinity ligand technology for identifying novel acetyltransferases; innovative mass spectrometry technologies, including ones to quantify the dynamics of lysine modification in response to biological stimuli; a unique instrumentation system to profile lysine modification in single cells. These experimental approaches may permit dynamic assessment of epigenetic changes that occur in individual cells as they develop or age, or as cancer progresses. The TCNP project integrates "driving biological projects" centered on lysine acetylation, methylation, and ubiquitylation, training and technology dissemination efforts, and technology development. Because lysine modification is intertwined with human health, aging and disease at many levels, what we learn could have far-reaching implications.

For more information, please contact Jef Boeke.

 
 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer